TY - JOUR
T1 - Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas
AU - Richardson, Timothy E.
AU - Sathe, Adwait Amod
AU - Xing, Chao
AU - Mirchia, Kanish
AU - Viapiano, Mariano S.
AU - Snuderl, Matija
AU - Abdullah, Kalil G.
AU - Hatanpaa, Kimmo J.
AU - Walker, Jamie M.
N1 - Funding Information:
Matija Snuderl is supported in part by grants from the Friedberg Charitable Foundation and the Making Headway Foundation.
Publisher Copyright:
© 2021 American Association of Neuropathologists, Inc. All rights reserved.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Chromosomal instability due to mutations in genes guarding the stability of the genome is a well-known mechanism underlying tumorigenesis and malignant progression in numerous cancers. The effect of this process in gliomas is mostly unknown with relatively little research examining the effects of chromosomal instability on patient outcome and therapeutic efficacy, although studies have shown that overall/total copy number variation (CNV) is elevated in higher histologic grades and in cases with more rapid progression and shorter patient survival. Herein, we examine a 70-gene mRNA expression signature (CIN70), which has been previously shown to correlate tightly with chromosomal instability, in 2 independent cohorts of IDH-mutant astrocytomas (total = 241), IDH-wildtype astrocytomas (n = 228), and oligodendrogliomas (n = 128). Our results show that CIN70 expression levels correlate with total CNV, as well as higher grade, progression-free survival, and overall survival in both IDH-mutant and IDH-wildtype astrocytomas. In oligodendrogliomas, these mRNA signatures correlate with total CNV but not consistently with clinical outcome. These data suggest that chromosomal instability is an underlying factor in aggressive behavior and progression of a subset of diffuse astrocytomas. In addition, chromosomal instability may in part explain the poor response of diffuse gliomas to treatment and may serve as a future therapeutic target.
AB - Chromosomal instability due to mutations in genes guarding the stability of the genome is a well-known mechanism underlying tumorigenesis and malignant progression in numerous cancers. The effect of this process in gliomas is mostly unknown with relatively little research examining the effects of chromosomal instability on patient outcome and therapeutic efficacy, although studies have shown that overall/total copy number variation (CNV) is elevated in higher histologic grades and in cases with more rapid progression and shorter patient survival. Herein, we examine a 70-gene mRNA expression signature (CIN70), which has been previously shown to correlate tightly with chromosomal instability, in 2 independent cohorts of IDH-mutant astrocytomas (total = 241), IDH-wildtype astrocytomas (n = 228), and oligodendrogliomas (n = 128). Our results show that CIN70 expression levels correlate with total CNV, as well as higher grade, progression-free survival, and overall survival in both IDH-mutant and IDH-wildtype astrocytomas. In oligodendrogliomas, these mRNA signatures correlate with total CNV but not consistently with clinical outcome. These data suggest that chromosomal instability is an underlying factor in aggressive behavior and progression of a subset of diffuse astrocytomas. In addition, chromosomal instability may in part explain the poor response of diffuse gliomas to treatment and may serve as a future therapeutic target.
KW - Astrocytoma
KW - Chromosomal instability
KW - Copy number variation
KW - Glioblastoma
KW - Glioma
KW - IDH-mutation
KW - Oligodendroglioma
UR - http://www.scopus.com/inward/record.url?scp=85103433792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103433792&partnerID=8YFLogxK
U2 - 10.1093/jnen/nlab008
DO - 10.1093/jnen/nlab008
M3 - Article
C2 - 33755138
AN - SCOPUS:85103433792
SN - 0022-3069
VL - 80
SP - 354
EP - 365
JO - Journal of neuropathology and experimental neurology
JF - Journal of neuropathology and experimental neurology
IS - 4
ER -